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patients was 43 (+/-8) years in the physiotherapy group, 46 (+/-11) years in the brace group and 47 (+/-9) years in the combined intervention group. It was not stated whether some patients refused to participate or were excluded, for any reasons, from the study sample.
Study design
This was a prospective RCT that was carried out at the authors' institution. A blinded researcher performed the randomisation process using a computer program. The length of follow-up was 12 months. The outcomes were evaluated at 6 and 52 weeks after randomisation. At 1 year, follow-up data were available for 168 (93%) patients, of whom 63 (93%) were from the brace group, 52 (93%) from the physiotherapy group and 53 (95%) from the combined intervention group. A researcher, blinded to patient allocation to treatment group, evaluated the clinical end points.
Analysis of effectiveness
The primary clinical end points were: a global measure of improvement on a 6-point scale (1 -completely recovered; 6 -much worse); severity of the patients' complaints on an 11-point scale (0 -no complaints; 11 -serious complaints); pain intensity of the patient's most serious complaint on an 11-point scale (0 -no pain; 11 -severe pain); and quality of life (assessed using the EuroQol).
The analysis of the clinical study was conducted on an intention to treat basis. At baseline, the study groups were comparable in terms of the demographic and clinical characteristics.
Effectiveness results
At the 1-year follow-up assessment, all clinical end points were comparable between the groups. Differences between the groups did not reach statistical or clinical significance.
For example, the values of quality of life (utilities) were 0.12 (+/-0.16) in the physiotherapy group, 0.17 (+/-0.29) in the brace group and 0.18 (+/-0.30) in the combined intervention group. Similarly, the success rate (i.e. the percentage of patients with improvement) was 89% in the physiotherapy group, 86% in the brace group and 87% in the combined intervention group.
Clinical conclusions
The effectiveness analysis showed that the three treatments of tennis elbow were similarly effective.
Measure of benefits used in the economic analysis
The summary benefit measures used were the clinical end points estimated in the RCT. No discounting was performed, which was appropriate given the short time horizon of the analysis.
Direct costs
The analysis of the costs was carried out from a societal perspective. The direct costs included were for GP visits, physiotherapy visits, medical specialist visit in the outpatient setting, hospital stay, professional home care, acupuncture, brace and chiropractor. Both medical and non-medical direct costs were included. The unit costs and the resource quantities were presented separately. Resource consumption was collected from the sample of patients enrolled in the clinical trial, using standard forms for physiotherapists and questionnaires filled out at 6, 26 and 52 weeks' follow-up. The costs were estimated using typical Dutch sources, such as the Dutch guidelines for cost analysis in health care research, the tariffs of the Dutch Central Organisation for Health Care Charges, professional organisations and the Royal Dutch Society for Pharmacy. Discounting was not relevant as the costs were incurred during a 12-month timeframe. The price year was not given.
Statistical analysis of costs
The costs in the different groups were compared using bootstrapping for pair-wise comparisons and generating 95% confidence intervals (CIs). Missing cost data were replaced by the mean of the measured costs as less than 5% of the total data were missing.
Indirect Costs
Productivity costs were included in the analysis, which was appropriate given the societal perspective used. Both paid and unpaid labour, and help from partners/friends, was taken into account. The unit costs and the quantities of resources used were reported separately. Resource use was derived from actual data in the RCT. The cost of unpaid labour was based on a shadow price. The cost of paid labour was estimated using the friction cost approach. As in the analysis of the direct costs, no discounting was performed and the price year was not explicitly reported (although it might have been 2004).
Currency
Euros (EUR). The exchange rate to US dollars ($) at February 2004 was EUR 1 = $1.26.
Sensitivity analysis
The issue of uncertainty was implicitly addressed by calculating bootstrapped CIs around cost-effectiveness and costutility ratios. A sensitivity analysis was carried out in which two alternative scenarios for costs were considered. In one scenario the cost of sick leave was based on a patient's true salary versus the mean income of the Dutch population by age and gender. In the other scenario, the influence of labour intensity (light or heavy) on work absenteeism was considered.
Estimated benefits used in the economic analysis
See the 'Effectiveness Results' section.
Cost results
The direct costs were EUR 417 (+/-386) in the physiotherapy group, EUR 564 (+/-1,173) in the brace group and EUR 518 (+/-802) in the combined intervention group.
The indirect costs were EUR 557 (+/-1,851) in the physiotherapy group, EUR 1,416 (+/-2,890) in the brace group and EUR 739 (+/-2,072) in the combined intervention group.
The total costs were EUR 975 (+/-1,989) in the physiotherapy group, EUR 1,980 (+/-3,673) in the brace group and EUR 1,258 (+/-2,403) in the combined intervention group.
None of the differences between groups reached statistical significance, although physiotherapy was the cheapest intervention.
The direct costs were comparable between groups, but the indirect costs were significantly higher in the brace only group compared with the physiotherapy group.
Synthesis of costs and benefits
Incremental cost-effectiveness ratios and cost-utility ratios were calculated in order to combine the costs and benefits of the alternative strategies. The authors also calculated incremental ratios in many cases of dominance, although these are meaningless. In general, the incremental analysis revealed the following results:
the comparison between physiotherapy and brace favoured the physiotherapy strategy, which was less costly and had similar clinical profiles (dominant when the measure of benefit was success rate, severity of complaint or pain for the most serious complaint); the comparison between brace and the combined therapy favoured the combined intervention, which was also less costly and had similar benefit results (dominant when measure of benefit was success rate, severity of complaint and quality of life);
in the comparison between physiotherapy and the combination therapy, physiotherapy was less costly and had similar benefit results.
However, all the incremental cost-effectiveness ratios showed very large confidence intervals around the mean estimates, ranging from dominance to very high values.
The base-case results were confirmed in the two sensitivity analyses that considered alternative cost scenarios.
